Click on the Session Title to view the recorded session.

Saturday 7/26

8:45a Welcome and Opening Remarks

9:00a The Role of Physical Therapy in Cystic Fibrosis	9:00a Eludicating the Ion Transport Functions of CFTR High Expresser Cells (CHEs) and its Relevance to Intestinal Disease in CF
9:55a Aging with CF	9:55a Optimization of Phage Therapy to Reduce Pseudomonas-Induced Inflammation in CF
10:55a Reproductive Health in People with CF	10:55a Designing a CF Gene Therapy Nanocarrier Platform to Target and Modify Airway Stem Cell-Derived Ionocytes
11:50a Increased Risk of GI and Other Cancers in People with CF	11:50a Characterization of Ionocyte Subtypes in Cystic Fibrosis Ferrets
1:45p Emerging Cardiovascular and Metabolic Risk Factors in the Era of Highly Effective CFTR Modulators	1:45p A Hybrid Gene Correction Strategy for Cystic Fibrosis – Anais Amaya, PhD; Matthew Porteus, MD, PhD
2:40p Living to Dream or Fighting to Breathe? Why Cystic Fibrosis Isn’t Equal for All	2:40p Corrected CFTR-F508del is Targeted for Endolysosomal Degradation
3:40p Nucleic Acid Based Approaches to Treat CF	3:40p Optimization of Activity and Improved Delivery of Bacteriophages Targeting Burkholderia spp